STAAR Surgical (STAA) Earnings Analysis

STAAR Surgical (STAA) next reports earnings on 2026-08-12, consensus EPS 0.21 USD. Last quarter (2026-03-03) it missed with EPS -0.2 USD vs 0.18 USD est (-211.1%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -58.83.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does STAA next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate0.21 USD
Revenue estimate0.09B

STAA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-03-0.2 USD0.18 USD-211.1%Miss
2024-10-300.37 USD0.19 USD+94.7%Beat

Beat rate: 1/2 (50%) over reported quarters with consensus data.

STAA valuation and analyst view

Trailing P/E-58.83
Trailing EPS-0.4214 USD
Price / book3.50
Dividend yield0.00%
Market cap1.23B
Analyst consensusHold (4 buy / 10 hold / 1 sell)
Avg price target32.6 USD

Related research pages

Frequently asked questions

When is STAAR Surgical (STAA)'s next earnings date?

STAAR Surgical is next scheduled to report on 2026-08-12, with a consensus EPS estimate of 0.21 USD and revenue estimate of 0.09B.

Did STAA beat earnings last quarter?

In its 2026-03-03 report, STAA posted EPS of -0.2 USD versus a 0.18 USD estimate — a miss of 211.1%.

What is STAA's earnings track record?

Over the last 2 reported quarters with consensus data, STAA beat estimates 1 times (50%).

What is STAA's current P/E ratio and EPS?

STAA trades at a trailing P/E of -58.83 on trailing EPS of -0.42139536747615614 USD.

What do analysts rate STAA?

Analyst consensus is "Hold" across 15 ratings (0 strong buy, 4 buy, 10 hold, 1 sell, 0 strong sell). Average 12-month price target: 32.6 USD.